Journal article icon

Journal article

Rapid oxygen release from stored red blood cells can be preserved for longer with refined additive solutions

Abstract:
Background: Stored red blood cells (RBCs) progressively lose metabolic and structural features that are critical for efficient oxygen release, potentially reducing transfusion efficacy. Compared to the standard storage additive saline‐adenine‐glucose‐mannitol (SAGM), successive refinements such as phosphate‐adenine‐glucose‐guanosine‐saline‐mannitol (PAGGSM) and SOLX (AS‐7) have demonstrated better preservation of metabolic and structural properties. Measuring RBC oxygen release permits further evaluation of such refinements within, and beyond, current storage durations. Study Design and Methods: Leukoreduced whole blood (WB) units from six pools of three ABO/Rh‐matched donors were processed into red cell concentrates and stored in SAGM, PAGGSM, or SOLX under standard blood bank conditions for 56 days. Periodic sampling during storage assessed hemolysis, adenosine 5'‐triphosphate (ATP) content, and oxygen‐unloading kinetics measured by single‐cell oxygen saturation imaging or estimated by FlowScore recorded on a hematology analyzer. Results: Hemolysis remained below the European regulatory threshold of 0.8% to day 49 in all units, with SOLX‐stored units showing less variation and more consistent late‐stage compliance. SOLX‐stored units preserved ATP for longer than SAGM and PAGGSM. Oxygen unloading from SOLX‐ and PAGGSM‐stored RBCs was faster than with SAGM; a similar effect was reported for FlowScore, indicating the utility of this surrogate to benchmark additive solutions. Overall, storage in SOLX halved the rate of attrition in oxygen release kinetics, with a statistically significant benefit emerging by week 3 of storage. Conclusion: Over 56 days, SOLX‐ and PAGGSM‐stored RBCs demonstrated faster oxygen release kinetics than SAGM, as measured directly and by the flow‐cytometric surrogate. Additionally, SOLX‐stored RBCs maintained better ATP levels and hemolysis compliance.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/trf.18452

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Role:
Author
ORCID:
0000-0001-8596-4420


Publisher:
Wiley
Journal:
Transfusion More from this journal
Publication date:
2025-10-22
Acceptance date:
2025-10-03
DOI:
EISSN:
1537-2995
ISSN:
0041-1132


Language:
English
Keywords:
Pubs id:
2305743
Local pid:
pubs:2305743
Source identifiers:
3395833
Deposit date:
2025-10-22
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP